Medtronic Q1 2025 Adj. EPS $1.23 Beats $1.20 Estimate, Sales $7.915B Beat $7.893B Estimate
Portfolio Pulse from Benzinga Newsdesk
Medtronic reported its Q1 2025 earnings, with adjusted EPS of $1.23 beating the estimate of $1.20, and sales of $7.915 billion surpassing the expected $7.893 billion.
August 20, 2024 | 10:46 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic's Q1 2025 earnings report shows a positive performance with adjusted EPS of $1.23 beating the $1.20 estimate, and sales of $7.915 billion exceeding the $7.893 billion forecast.
Medtronic's better-than-expected earnings and sales figures are likely to positively impact its stock price in the short term. Beating both EPS and sales estimates suggests strong operational performance, which is typically viewed favorably by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100